Serevent Diskus is a brand name of salmeterol, approved by the FDA in the following formulation(s):
SEREVENT (salmeterol xinafoate - powder; inhalation)
Manufacturer: GLAXO GRP LTD
Approval date: September 19, 1997
Strength(s): EQ 0.05MG BASE/INH [RLD]
Has a generic version of Serevent Diskus been approved?
No. There is currently no therapeutically equivalent version of Serevent Diskus available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Serevent Diskus. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Inhalation device
Patent 5,590,645
Issued: January 7, 1997
Inventor(s): Davies; Michael B. & Hearne; David J. & Rand; Paul K. & Walker; Richard I.
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 5,860,419
Issued: January 19, 1999
Inventor(s): Davies; Michael Birsha & Hearne; David John & Rand; Paul Kenneth & Walker; Richard Ian
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 5,873,360
Issued: February 23, 1999
Inventor(s): Davies; Michael Birsha & Hearne; David John & Rand; Paul Kenneth & Walker; Richard Ian
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- February 23, 2016✓
- August 23, 2016✓
- February 23, 2016
Inhalation device
Patent 6,032,666
Issued: March 7, 2000
Inventor(s): Davies; Michael Birsha & Hearne; David John & Rand; Paul Kenneth & Walker; Richard Ian
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 6,378,519
Issued: April 30, 2002
Inventor(s): Michael Birsha; Davies & David John; Hearne & Paul Kenneth; Rand & Richard Ian; Walker
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 6,536,427
Issued: March 25, 2003
Inventor(s): Michael Birsha; Davies & David John; Hearne & Paul Kenneth; Rand & Richard Ian; Walker & James Barry Douglas; Palmer
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 6,792,945
Issued: September 21, 2004
Inventor(s): Michael Birsha; Davies & David John; Hearne & Paul Kenneth; Rand & Richard Ian; Walker
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 7,225,808
Issued: June 5, 2007
Inventor(s): Davies; Michael Birsha & Hearne; David John & Rand; Paul Kenneth & Walker; Richard Ian
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
Inhalation device
Patent 7,389,775
Issued: June 24, 2008
Inventor(s): Davies; Michael Birsha & Hearne; David John & Rand; Paul Kenneth & Walker; Richard Ian
Assignee(s): Glaxo Group Limited
An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.Patent expiration dates:
- September 1, 2011✓
- September 1, 2011
See also...
- Serevent Consumer Information (Drugs.com)
- Serevent Diskus Consumer Information (Wolters Kluwer)
- Serevent Diskus inhalation Consumer Information (Cerner Multum)
- Serevent Advanced Consumer Information (Micromedex)
- Serevent Diskhaler Disk Advanced Consumer Information (Micromedex)
- Serevent Diskus Advanced Consumer Information (Micromedex)
- Severent Advanced Consumer Information (Micromedex)
- Severent Diskhaler Advanced Consumer Information (Micromedex)
- Severent Diskus Advanced Consumer Information (Micromedex)
- Serevent AHFS DI Monographs (ASHP)
- Salmeterol Consumer Information (Wolters Kluwer)
- Salmeterol inhalation Consumer Information (Cerner Multum)
- Salmeterol Inhalation Advanced Consumer Information (Micromedex)
- Salmeterol Xinafoate AHFS DI Monographs (ASHP)
No comments:
Post a Comment